Description

Adenuric (febuxostat) Coated Tablets 120 mg. №28

Ingredients

Active ingredient: Febuxostat 120 mg.
Other ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate.

Dosage

Recommended dosage: The usual dose is one 120 mg tablet once daily. It is important to follow the instructions provided by your healthcare provider.

Indications

Adenuric tablets are indicated for the management of hyperuricemia in conditions where urate deposition has already occurred or is predictable.

Contraindications

Do not use Adenuric if:

• You are allergic to febuxostat or any other ingredients in the product.
• You are pregnant or breastfeeding.
• You have severe liver or kidney problems.

Directions

How to take: Swallow the tablet whole with water. It can be taken with or without food. Do not crush or chew the tablet.

Scientific Evidence

Studies have shown that febuxostat effectively lowers serum uric acid levels in patients with hyperuricemia. One study published in the New England Journal of Medicine demonstrated that febuxostat was non-inferior to allopurinol in lowering uric acid levels.

Additional Information

Storage: Store at room temperature away from moisture and heat. Keep out of reach of children.
Side effects: Common side effects may include nausea, liver function abnormalities, and rash. Consult your doctor if any side effects persist or worsen.

Pharmacological Effects: Febuxostat is a xanthine oxidase inhibitor that works by decreasing the production of uric acid in the body. By lowering uric acid levels, it helps prevent gout attacks and reduces the risk of uric acid kidney stones.

Clinical Trials: Clinical trials have shown that febuxostat is effective in reducing serum uric acid levels and maintaining them within the recommended range. A study published in Arthritis & Rheumatology found that febuxostat was well-tolerated and effective in lowering uric acid levels over a 12-month period.